ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Trulieve Cannabis's annualizedNet Income for the quarter that ended in Mar. 2026 was $10 Mil.
Trulieve Cannabis's average Total Assets over the quarter that ended in Mar. 2026 was $2,739 Mil. Therefore, Trulieve Cannabis's annualized ROA % for the quarter that ended in Mar. 2026 was 0.35%.
The historical rank and industry rank for Trulieve Cannabis's ROA % or its related term are showing as below:
TRLV'
s ROA % Range Over the Past 10 Years
Min: -37.31 Med: -4.86 Max: 19.38
Current: -2.85
During the past 10 years, Trulieve Cannabis's highest ROA % was 19.38%. The lowest was -37.31%. And the median was -4.86%.
TRLV's ROA % is ranked worse than 70.68% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 2.685
vs TRLV: -2.85
Trulieve Cannabis (NYSE:TRLV) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Trulieve Cannabis ROA % Related Terms
Trulieve Cannabis ROA % Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's ROA % distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Trulieve Cannabis (TRLV) has a ROA % of 0.35% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Trulieve Cannabis and its competitors. According to the industry distribution chart, Trulieve Cannabis ranks #711 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 70.7%.
Is Trulieve Cannabis' ROA % too high?
Trulieve Cannabis' current ROA % is 0.35%. The Drug Manufacturers industry median ROA % is 2.69. Trulieve Cannabis' value of 0.35% is 87% below this industry median. Based on the distribution chart, Trulieve Cannabis ranks #711 out of 1006 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Trulieve Cannabis has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' ROA % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #711 out of 1006 companies for ROA %. This places Trulieve Cannabis in the lower half of its industry. The industry median ROA % is 2.69. Trulieve Cannabis' value of 0.35% is 87% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.69, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current ROA % of 0.35% is 87% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current ROA % is 0.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (TRLV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.03, compared to a current price of $8.50 — trading 41% above its estimated fair value. The current ROA % is 0.35% and 87% below the Drug Manufacturers industry median of 2.69. Trulieve Cannabis' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Trulieve Cannabis (TRLV), the current ROA % is 0.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (TRLV) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of $8.50 is trading 41% above its estimated GF Value™ of $6.03.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for TRLV:
ROA %: 0.35%
GF Value™: $6.03 vs. price of $8.50 (41% above fair value)
Industry Position: 87% below the Drug Manufacturers median (#711 of 1006)
No single metric tells the full story. See the TRLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
63GF Score
Get the complete analysis for TRLV
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRLV has been successfully added to your 
